Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, biotechnology, life sciences, animal health, crop protection, and specialty chemicals industries. The company operates in two segments, Pharmaceuticals and Crop Protection.
Hikal Limited (HIKAL) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The HIKAL share price is ₹220.60 (-0.14% today), with a market capitalisation of ₹27B. MarketRipple tracks the HIKAL investment thesis, the ripple-chain impact of market events on Hikal Limited, and the Healthcare sector outlook.
Open
₹219.89
High
₹221.82
Low
₹219.00
Prev. Close
₹220.90
52W High
₹261.00
52W Low
₹146.25
Day range
₹219.00–₹221.82
52-week range
₹146.25–₹261.00
Volume
85K
P/E
—
ROE
-0.4%
D/E
0.57
Margin
-0.3%
Hikal Limited (NSE: HIKAL) is currently trading at ₹220.60 (-0.14%).
Hikal Limited's market capitalization is ₹27B.
Hikal Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Hikal Limited currently reads neutral, based on 1 analyst covering the stock. This is third-party analyst data, not a MarketRipple recommendation.